Market-Moving News for August 24th
Portfolio Pulse from ryanfaloona@benzinga.com
NVIDIA, Guess?, and Taysha Gene Therapies shares are trading higher. NVIDIA reported better-than-expected Q2 results, issued Q3 revenue guidance above estimates, and approved an additional $25 billion in share repurchases. Guess? also reported better-than-expected Q2 results and issued FY24 EPS guidance above estimates. Taysha Gene Therapies received Fast Track Designation from the U.S. FDA for TSHA-102 in Rett Syndrome.
August 24, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guess? reported better-than-expected Q2 results and issued FY24 EPS guidance above estimates.
Guess?'s positive Q2 results and upbeat FY24 EPS guidance are likely to increase investor confidence and push the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
NVIDIA reported better-than-expected Q2 results, issued Q3 revenue guidance above estimates, and approved an additional $25 billion in share repurchases.
NVIDIA's strong Q2 results and optimistic Q3 guidance, coupled with the approval of a significant share repurchase program, are likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Taysha Gene Therapies received Fast Track Designation from the U.S. FDA for TSHA-102 in Rett Syndrome.
The FDA's Fast Track Designation for Taysha Gene Therapies' TSHA-102 in Rett Syndrome is likely to expedite the drug's development and review process, potentially leading to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100